Cipla Shares Drop 5% After Temporary Halt at Key Drug Facility
On January 16, 2026, Cipla shares fell sharply as markets reacted to news that the company had temporarily stopped production of a key drug. The stock slid by around 4.5–5%, trading near its intraday lows on the BSE. This decline reflects rising investor concern about future revenue and supply disruption.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
